Skip to content
- WORX: Back on Nasdaq, SCWorx’s Recovery Faces an Earnings Test
- AIBZ: Bitzero’s AI Infrastructure Story Needs Tenants, Not Just Attention
- Drone Frames, Bitcoin Tokens and Biotech Cash: Behind the Penny-Stock Gainers
- TCRT: A $350 Million Biotech Deal Makes Dilution the Essential Question
- SITC: A $3 Cash Distribution Comes With a NYSE Exit—and a Trading Catch
- ATOS: The Potential $50 Million Shareholder Payout Is a Conditional Right
- MWYN: Marwynn’s AI and Digital-Asset Ambitions Face a Revenue Test
- SEED: Fresh Capital and Stress-Tolerant Corn Give Origin Agritech a New Story
- CCEL: Cryo-Cell Earns More Without Growing Sales—Can It Last?
- XELB: Can Jenny Martinez’s Online Audience Become a Grocery Business?
